1,10-bis(carboxymethylthiodecane) has been researched along with tiadenol in 1 studies
| Studies (1,10-bis(carboxymethylthiodecane)) | Trials (1,10-bis(carboxymethylthiodecane)) | Recent Studies (post-2010) (1,10-bis(carboxymethylthiodecane)) | Studies (tiadenol) | Trials (tiadenol) | Recent Studies (post-2010) (tiadenol) |
|---|---|---|---|---|---|
| 19 | 0 | 0 | 69 | 5 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aarsaether, N; Aarsland, A; Berge, RK; Bremer, J | 1 |
1 other study(ies) available for 1,10-bis(carboxymethylthiodecane) and tiadenol
| Article | Year |
|---|---|
The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester.
Topics: Acyl Coenzyme A; Animals; Cholesterol; Dicarboxylic Acids; Electrophoresis, Polyacrylamide Gel; Fatty Alcohols; Hypolipidemic Agents; Liver; Male; Microbodies; Oxidation-Reduction; Rats; Rats, Inbred Strains; Sulfides; Triglycerides | 1990 |